Gates Foundation Strategic Investment Fund Logo
>
Share this page:

Dr. Reddy’s molnupiravir

The foundation provided support to Dr. Reddy’s Laboratories, a multinational pharmaceutical company, to expand access to generic molnupiravir in low- and middle-income countries.

 

Investment Date: March 2022